Innosuisse
Federal · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Einsteinstrasse 2, Bern, Bern, 3003, Swi...Phone Number
+41 584616161Website
www.innosuisse.chRevenue
$6.8 MillionIndustry
About Innosuisse
Is Innosuisse your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Innosuisse launches new products
Innosuisse, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Innosuisse recently announced quarterly report
Check out if Innosuisse is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Innosuisse
Check if Innosuisse has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Innosuisse has new funding data
Click to see if Innosuisse had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Innosuisse as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Innosuisse is experiencing very low activity levels compared to other companies in the Government sector.
What does this means?
Innosuisse is drawing exceptional interest within the Government industry, suggesting notable developments or strong market momentum, learn more about Innosuisse.
Innosuisse Tech Stack
A closer look at the technologies used by Innosuisse
Most Recent Scoops
Innosuisse News & Media
Araris Biotech AG Supported with CHF 2.5M Swiss Accelerator Grant from Innosuisse to Develop Antibody-Drug Conjugate Candidates
AU ZH, Switzerland, May 05, 2023 (GLOBE NEWSWIRE) -- Araris Biotech AG (“Araris” or “the Company”), a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology, today announced that, Innosuisse, the Swiss innovation agency committed to promote science-based innovation in the interest of the economy and society in Switzerland, has supported Araris with CHF 2.5M non-dilutive grant funding through the Swiss Accelerator program for the development and advancement of its ADC caAude Pugin and Sergio Ermotti Elected as New Innosuisse Board of Directors
On 9 December, the Federal Council elected Aude Pugin, CEO of APCO Technologies, and Sergio Ermotti, Chairman of the Board of Directors of Swiss Re Group, to the Board of Directors of Innosuisse.Gnubiotics Sciences Announces Funding from the Swiss Innovation Agency to Accelerate Development of Glycopeptide Mediated Immunotherapies against Solid Tumors
LAUSANNE, Switzerland--(BUSINESS WIRE)--Gnubiotics Sciences, a biotech company pioneering the discovery and development of immunomodulatory glycopeptides, today announced that the Swiss Innovation Agency (Innosuisse) will support a research collaboration with the University Hospital Zürich to accelerate the development of Gnubiotics’ GLAAD technology in a range of solid tumors. The total project cost of CHF 1.4 million (USD 1.4 million) will be supported by the grant from Innosuisse as well asHAYA Therapeutics Announces Funding from Swiss Innovation Agency Supporting Research Collaborations for Long Non-Coding RNA Therapies
LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)-- #Innosuisse--HAYA Therapeutics announces funding from Swiss Innovation Agency supporting research collaborations for Long Non-Coding RNA Therapies
Top Federal Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Innosuisse
Innosuisse is the Swiss Agency for Innovation Promotion, supporting SMEs, start-ups, research institutions, and other Swiss organizations in their research and development activities. The agency facilitates collaboration and knowledge transfer to develop promising new products or services, both nationally and internationally. Innosuisse offers vari... Read More